Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 1 September 2005, Vol. 106, No. 5, pp. 1778-1785.
Prepublished online as a Blood First Edition Paper on May 19, 2005; DOI 10.1182/blood-2005-01-0143.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Tables
Right arrow All Versions of this Article:
2005-01-0143v1
106/5/1778    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaza, G.
Right arrow Articles by Evans, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaza, G.
Right arrow Articles by Evans, W. E.
Related Collections
Right arrow Neoplasia
Right arrow Gene Expression
Right arrow Free Research Articles
Right arrowRelated Article in Blood Online
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

NEOPLASIA

Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment

Gianluigi Zaza, Meyling Cheok, Wenjian Yang, John C. Panetta, Ching-Hon Pui, Mary V. Relling, and William E. Evans

From the Hematological Malignancies Program and the Departments of Pharmaceutical Sciences and Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN; University of Bari, Bari, Italy; University of Tennessee, Memphis, TN.

To elucidate interpatient variability in thioguanine nucleotide (TGN) concentrations in acute lymphoblastic leukemia (ALL) cells, we determined the TGN concentrations in leukemic blasts from 82 children with newly diagnosed ALL after intravenous administration of mercaptopurine (MP). Patients treated with MP alone achieved higher TGN concentrations than those treated with the combination of methotrexate plus mercaptopurine (MTX + MP). Analysis of the expression of approximately 9600 genes in ALL cells obtained at diagnosis identified 60 gene probes significantly associated with TGN accumulation in patients treated with MP alone and 75 gene probes in patients treated with MTX + MP, with no overlap between the 2 sets of genes. Genes significantly associated with intracellular TGN accumulation after MP alone included those encoding MP metabolic enzymes and transporters (eg, SLC29A1). Inhibition of SLC29A1 by nitrobenzylmercaptopurine ribonucleoside (NBMPR) caused a 33% to 45% reduction of TGN in ALL cells in vitro (P < .006), consistent with the gene expression findings. Genes associated with TGN concentration after combination therapy included those involved in protein and adenosine triphosphate (ATP)-biosynthesis. Together, these in vivo and in vitro data provide new insight into the genomic basis of interpatient differences in intracellular TGN accumulation and reveal significant differences between treatment with MP alone and treatment with MP and MTX. (Blood. 2005;106:1778-1785)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

More and more about less and less
Bruce Matthew Camitta
Blood 2005 106: 1512. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 The Journal of RheumatologyHome page
A. D. ASKANASE, D. J. WALLACE, M. H. WEISMAN, C.-E TSENG, L. BERNSTEIN, H. M. BELMONT, E. SEIDMAN, M. ISHIMORI, P. M. IZMIRLY, and J. P. BUYON
Use of Pharmacogenetics, Enzymatic Phenotyping, and Metabolite Monitoring to Guide Treatment with Azathioprine in Patients with Systemic Lupus Erythematosus
J Rheumatol, January 1, 2009; 36(1): 89 - 95.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Krishnamurthy, M. Schwab, K. Takenaka, D. Nachagari, J. Morgan, M. Leslie, W. Du, K. Boyd, M. Cheok, H. Nakauchi, et al.
Transporter-Mediated Protection against Thiopurine-Induced Hematopoietic Toxicity
Cancer Res., July 1, 2008; 68(13): 4983 - 4989.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Flotho, E. Coustan-Smith, D. Pei, S. Iwamoto, G. Song, C. Cheng, C.-H. Pui, J. R. Downing, and D. Campana
Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2
Blood, August 1, 2006; 108(3): 1050 - 1057.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C.-H. Pui and W. E. Evans
Treatment of Acute Lymphoblastic Leukemia
N. Engl. J. Med., January 12, 2006; 354(2): 166 - 178.
[Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020